Guardion Health Science (GHSI) - Dana dhuwit diétung saben saham

The implementation of AI manipulators in capsule production could boost capitalization, as evidenced by the cash per share trend, where the value is fixed at 11.55. Guardion Health Science (GHSI) revenues are based on the sale of Lumega-Z nutraceuticals designed to combat retinal degeneration. Physician confidence is driven by scientifically proven formulas that slow vision loss, creating a sustainable market advantage.
Rincian metrik komprehensif lan analitis Guardion Health Sciences (GHSI)

This metric is calculated by dividing the total cash balance by the number of shares outstanding. This figure compares current capital with historical context to assess financial stability or stagnation. For Guardion Health Science (GHSI), the value 11.55 reflects the liquidity required to automate production lines for ophthalmological nutraceuticals. Investments in AI manipulators directly impact the dynamics of this reserve. By analyzing the current cash per share, an investor determines the company's ability to fund technological expansion.